Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 565,000 | 8M | 8M | 13M | 475,000 | 967,000 |
| Cost of revenue | 544,000 | 6M | 6M | 6M | 295,000 | 850,000 |
| Gross profit | 21,000 | 3M | 2M | 7M | 180,000 | 117,000 |
| Research and development | 13M | 11M | 12M | 9M | 12M | 12M |
| Selling, general and administrative | 25M | 519M | 23M | 23M | 17M | 17M |
| Operating income | −58M | −538M | −43M | −35M | −41M | −42M |
| Pre-tax income | −47M | −533M | −38M | −30M | −46M | −74M |
| Income tax | — | — | — | — | 12,000 | 0 |
| Net income | −44M | −273M | −18M | −14M | −17M | −28M |
| Earnings per share | −0.14 | −1.85 | −0.13 | −0.11 | −0.18 | −0.31 |
| Earnings per share, diluted | −0.14 | −1.85 | −0.13 | −0.11 | −0.18 | −0.31 |
| Weighted average shares | 320M | 148M | 133M | 128M | 95M | 90M |
| Weighted average shares, diluted | 320M | 148M | 133M | 128M | 95M | 90M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 341M | 836M | 408M | 298M | 491M | 402M | 117M | 136M |
| Short-term investments | 549M | 418M | 284M |
| Metric | 31/03/2026 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|
| Operating cash flow | −315M | — | −23M | — | — |
| Depreciation and amortisation | 309,000 | 260,000 | 269,000 | 394,000 | 402,000 |
| Share-based compensation |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 123M |
| 30M |
| 40M |
| 45M |
| — |
| Current assets | 908M | 1.27B | 720M | 443M | 543M | 471M | 181M | 156M |
| Property, plant and equipment | 3M | 2M | 2M | 2M | 2M | 2M | 3M | 3M |
| Goodwill | 8M | 8M | 8M | 8M | 8M | 8M | 8M | 8M |
| Total assets | 1.15B | 1.41B | 883M | 606M | 618M | 545M | 253M | 229M |
| Current liabilities | 31M | 296M | 446M | 105M | 87M | 90M | 81M | 59M |
| Total liabilities | 38M | 299M | 448M | 108M | 89M | 92M | 163M | 136M |
| Equity | 1.17B | 1.17B | 829M | 499M | 529M | 619M | 90M | 93M |
| 5M |
| — |
| 4M |
| — |
| — |
| Capital expenditure | 2M | — | 67,000 | — | — |
| Investing cash flow | −218M | — | 10M | — | — |
| Financing cash flow | 38M | — | 103M | — | — |